Author: STEALTH BIOTHERAPEUTICS INC.

Posted Date:

April 8, 2026

Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company’s Pioneering Work in Mitochondrial Medicine

STEALTH BIOTHERAPEUTICS INC.

April 8, 2026
Stealth BioTherapeutics Announces MRC Business Engagement Fund Grant to Advance Mitochondrial Disease Research

STEALTH BIOTHERAPEUTICS INC.

March 23, 2026